Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionZurcher Kantonalbank (Zurich Cantonalbank)
Latest Disclosed Ownership52,373 shares
Latest Disclosed Value $ 1,646,083
Zurcher Kantonalbank (Zurich Cantonalbank) ownership in CPRX / Catalyst Pharmaceuticals, Inc.

On August 11, 2026 - Zurcher Kantonalbank (Zurich Cantonalbank) filed a 13F-HR form disclosing ownership of 52,373 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $1,646,083 USD as of June 30, 2026. The entity filed a previous 13F-HR on May 15, 2026 disclosing 52,974 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of -1.13% during the quarter. The current value of the position is $1,649,226 USD.

Zurcher Kantonalbank (Zurich Cantonalbank) has a history of taking positions in derivatives of the underlying security (CPRX) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CPRX / Catalyst Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-08-11 2026-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 52,373 -601 -1.13 1,646 25.55 0.0032
2026-05-15 2026-03-31 13F CATALYST PHARMACEUTICALS PUT 14888U101 0 -48,643 -100.00 0 -100.00
2026-05-15 2026-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 52,974 4,331 8.90 1,312 15.51 0.0029
2026-01-27 2025-12-31 13F CATALYST PHARMACEUTICALS PUT 14888U101 48,643 10,749 28.37 1,135 52.14 0.0025
2025-11-14 2025-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 37,894 6,004 18.83 747 7.80 0.0017
2025-08-07 2025-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 31,890 -7 -0.02 692 -10.48 0.0017
2025-05-07 2025-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 31,897 3,244 11.32 774 29.48 0.0022
2025-02-07 2024-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 28,653 3,573 14.25 598 19.88 0.0017
2024-11-14 2024-09-30 13F/A-1 CATALYST PHARMACEUTICALS COM 14888U101 25,080 388 1.57 499 30.37 0.0015
2024-11-08 2024-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 25,080 388 499 0.0015
2024-07-29 2024-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 24,692 0 0.00 382 -2.80 0.0012
2024-04-25 2024-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 24,692 0 0.00 394 -5.30 0.0014
2024-01-30 2023-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 24,692 0 0.00 415 44.10 0.0016
2023-10-25 2023-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 24,692 5,044 25.67 289 9.09 0.0013
2023-08-07 2023-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 19,648 0 0.00 264 -18.77 0.0012
2023-05-08 2023-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 19,648 4,425 29.07 326 14.84 0.0016
2023-02-01 2022-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 15,223 5,983 64.75 283 137.82 0.0015
2022-11-09 2022-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 9,240 0 0.00 119 83.08 0.0007
2022-08-09 2022-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 9,240 -7,295 -44.12 65 -52.55 0.0004
2022-04-21 2022-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 16,535 8,258 99.77 137 144.64 0.0007
2022-02-01 2021-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 8,277 1,373 19.89 56 51.35 0.0003
2021-11-15 2021-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 6,904 0 0.00 37 -7.50 0.0002
2021-07-30 2021-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 6,904 0 0.00 40 25.00 0.0002
2021-05-03 2021-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 6,904 0 0.00 32 39.13 0.0002
2021-01-28 2020-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 6,904 0 0.00 23 9.52 0.0001
2020-11-06 2020-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 6,904 0 0.00 21 -34.37 0.0001
2020-07-28 2020-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 6,904 0 0.00 32 18.52 0.0003
2020-05-06 2020-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 6,904 0 0.00 27 3.85 0.0003
2020-01-21 2019-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 6,904 0 0.00 26 -29.73 0.0002
2019-10-18 2019-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 6,904 595 9.43 37 54.17 0.0003
2019-07-30 2019-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 6,309 6,309 24 0.0002
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CATALYST PHARMACEUTICALS PUT 0 -100.00 0 -100.00 n/a n/a n/a
2026-01-27 2025-12-31 13F CATALYST PHARMACEUTICALS PUT 48,643 28.37 1,135 52.14 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.